NCT07057609View on ClinicalTrials.gov

Bioequivalence Study of Propofol Medium and Long Chain Fat Emulsion Injection in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

December 19, 2018

Study Completion Date

March 22, 2019

Conditions
Healthy
Interventions
DRUG

Tested Propofol Medium and Long Chain Fat Emulsion Injection (T)

Single-dose intravenous infusion of the test formulation under fasting conditions at 30 μg/kg/min. Infusion time: 30 minutes. Dosage: 900 μg/kg for both administrations

DRUG

Reference Propofol Medium and Long Chain Fat Emulsion Injection (R)

Single-dose intravenous infusion of the reference formulation under fasting conditions at 30 μg/kg/min. Infusion time: 30 minutes. Dosage: 900 μg/kg for both administrations

Trial Locations (1)

Unknown

the First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT07057609 - Bioequivalence Study of Propofol Medium and Long Chain Fat Emulsion Injection in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter